Literature DB >> 585416

Possible physiological significance of the initial step in the catabolism of noradrenaline in the central nervous system of the rat.

M B Farah, E Adler-Graschinsky, S Z Langer.   

Abstract

The hypothalamus, the cerebral cortex and the cerebellar cortex of the rat were labelled in vitro with 3H-noradrenaline (3H-NA) and the metabolism of the tritiated transmitter was studied during spontaneous outflow and under conditions of release elicited by exposure to 20 mM K+. In the three areas of the central nervous system of the rat 3H-NA accounted for approximately 40% of the total radioactivity in spontaneous outflow while the 3H-O-methylated deaminated fraction (3H-OMDA) and 3H-3,4-dihydroxyphenylglycol (3H-DOPEG) were the main metabolites. Exposure to the reserpine-like agent, Ro 4-1284 induced a selective increase in the spontaneous outflow of 3H-DOPEG, while the contribution of the 3H-OMDA metabolites to the release induced by Ro 4-1284 was very small. During 3H-transmitter release elicited by exposure to 20 mM K+, approximately 80% of the radioactivity was collected as unmetabolized 3H-NA, while 3H-DOPEG was the main metabolite formed under these experimental conditions. Exposure to cocaine prevented 3H-DOPEG formation from 3H-NA released by K+, indicating that 3H-DOPEG was formed after neuronal reuptake of the transmitter released by K+. After in vitro labelling with 3H-NA, the unmetabolized transmitter represented approximately 70% of the total radioactivity retained in the tissue. However, when 3H-NA was administered in vivo, by intraventricular injection, only 30% of the total radioactivity retained by the tissue was accounted for by 3H-NA, and 60% of the radioactivity corresponded to the 3H-OMDA fraction, most of which was retained as 3H-MOPEG sulfate. When the rats were pretreated with pyrogallol, free 3H-DOPEG accounted for nearly 50% of the radioactivity retained in the three areas of the central nervous system after in vivo labelling with 3H-NA. When monoamine oxidase was inhibited by pargyline and 3H-NA was administered by intraventricular injection, 3H-NMN accounted for approximately 50% of the total radioactivity retained in the three areas of the central nervous system of the rat. The results obtained are compatible with the view that formation of the deamined glycol is the first step in the metabolism of 3H-NA in the rat central nervous system. In addition, it is concluded that the determination of the levels of some NA metabolites retained in the central nervous system does not necessarily represent an accurate reflection of the degree of central noradrenergic activity or of selective metabolic pathways. Consequently, in studies on the metabolism of NA it is important to take into account not only the transmitter and its metabolites in the tissue but also in the outflow from the structures studied either under in vivo or in vitro conditions.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 585416     DOI: 10.1007/bf00499921

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  41 in total

Review 1.  Catechol-O-methyl transferase: pharmacological aspects and physiological role.

Authors:  H C Guldberg; C A Marsden
Journal:  Pharmacol Rev       Date:  1975-06       Impact factor: 25.468

2.  Estimation of noradrenaline and its major metabolites synthesized from [3H] tyrosine in the rat brain.

Authors:  M Nielsen
Journal:  J Neurochem       Date:  1976-08       Impact factor: 5.372

3.  Effects of flow-stop on the metabolism of noradrenaline released by nerve stimulation in the perfused spleen.

Authors:  M Dubocovich; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

4.  Stimulation and destruction of the locus coeruleus: opposite effects on 3-methoxy-4-hydroxyphenylglycol sulfate levels in the rat cerebral cortex.

Authors:  J Korf; G K Aghajanian; R H Roth
Journal:  Eur J Pharmacol       Date:  1973-03       Impact factor: 4.432

5.  Preferential metabolism of (-) 3 H-norepinephrine through the deaminated glycol in the rat vas deferens.

Authors:  K H Graffe; F J Stefano; S Z Langer
Journal:  Biochem Pharmacol       Date:  1973-05-15       Impact factor: 5.858

6.  Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite.

Authors:  S M Schanberg; J J Schildkraut; G R Breese; I J Kopin
Journal:  Biochem Pharmacol       Date:  1968-02       Impact factor: 5.858

7.  "Biogenic" aldehyde metabolism relation to pentose shunt activity in brain.

Authors:  B Tabakoff; W Groskopf; R Anderson; S G Alivisatos
Journal:  Biochem Pharmacol       Date:  1974-06-15       Impact factor: 5.858

8.  Intra- and extraneuronal formation of the two major noradrenaline metabolites in the cns of rats.

Authors:  C Braestrup; M Nielsen
Journal:  J Pharm Pharmacol       Date:  1975-06       Impact factor: 3.765

9.  Selective inhibition by hydrocortisone of 3H-normetanephrine formation during 3H-transmitter release elicited by nerve stimulation in the isolated nerve-muscle preparation of the cat nictitating membrane.

Authors:  M A Luchelli-Fortis; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

10.  The metabolism of (3H)noradrenaline released by electrical stimulation from the isolated nictitating membrane of the cat and from the vas deferens of the rat.

Authors:  S Z Langer
Journal:  J Physiol       Date:  1970-07       Impact factor: 5.182

View more
  15 in total

1.  Evidence for the presynaptic location of the alpha-adrenoceptors which regulate noradrenaline release in the rat submaxillary gland.

Authors:  E J Filinger; S Z Langer; C J Perec; F J Stefano
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-08       Impact factor: 3.000

2.  Mechanism of the enhancement in transmitter release from central and peripheral noradrenergic nerve terminals induced by the purified scorpion venom, tityustoxin.

Authors:  E Alder-Graschinsky; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-07       Impact factor: 3.000

3.  Influence of monoamine oxidase inhibition on the release of 3H-dopamine elicited by potassium and by amphetamine from the rat substantia nigra and corpus striatum.

Authors:  S Arbilla; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-02       Impact factor: 3.000

4.  Effects of gamma-aminobutyric acid on the potassium and tyramine induced release of [3Hi1-noradrenaline from rat occipital cortex slices [proceedings].

Authors:  S Arbilla; S Z Langer
Journal:  Br J Pharmacol       Date:  1978-06       Impact factor: 8.739

5.  Release and distribution of [3H]norepinephrine in nonpigmented and pigmented rabbit iris.

Authors:  M B Farah; P N Patil
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

6.  alpha-Adrenoceptor-mediated inhibition of noradrenaline release in rabbit brain cortex slices. Receptor properties and role of the biophase concentration of noradrenaline.

Authors:  D Reichenbacher; W Reimann; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-04       Impact factor: 3.000

7.  Pathways of dopamine metabolism in the rabbit caudate nucleus in vitro.

Authors:  A Zumstein; W Karduck; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-06       Impact factor: 3.000

8.  Brain cortical tissue levels of noradrenaline and its glycol metabolites: effects of ischemia and postischemic administration of idazoxan.

Authors:  I Gustafson; A Lidén; T Wieloch
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

9.  The K+-induced increases in noradrenaline and dopamine release are accompanied by reductions in the release of their intraneuronal metabolites from the rat anterior hypothalamus. An in vivo brain microdialysis study.

Authors:  E Badoer; H Würth; D Türck; F Qadri; K Itoi; P Dominiak; T Unger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

10.  Metabolic fate of 3H-noradrenaline released from the mouse hypothalamus.

Authors:  E Adler-Graschinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.